Man Reverses Advanced Liver Fibrosis in a Year With Diet and Strength Training
A man with severe obesity lost 33.8% of his body weight and cut liver stiffness by 80.6% in 12 months, with proteomics pointing to neutrophil NETosis activity.
Summary
This case report describes a man in his 30s with severe obesity (BMI 35.2) and advanced liver fibrosis (liver stiffness 18 kPa) due to metabolic dysfunction-associated steatotic liver disease (MASLD). Over 12 months he followed caloric restriction plus resistance training, lost 33.8% of his body weight while keeping skeletal muscle, and normalized his liver enzymes. His liver stiffness fell by 80.6%. Blood proteomic comparison before and after showed that the neutrophil extracellular trap (NET) formation pathway was the most strongly upregulated, while metabolic pathways were downregulated. Key NETosis proteins such as PAD4, neutrophil elastase, myeloperoxidase and citrullinated histone H3 were increased. The authors suggest neutrophil-mediated immune regulation may help drive fibrosis regression. As a single case, it generates hypotheses rather than proving cause and effect.
Detailed Summary
Advanced fibrosis is the strongest predictor of poor outcomes in MASLD, and cirrhosis can follow. Lifestyle change is the first-line treatment, but little is known about the molecular events behind regression of advanced fibrosis, which limits efforts to find biomarkers or targets.
The authors report a man in his 30s with severe obesity (BMI 35.2 kg/m²) and advanced fibrosis (liver stiffness measurement 18 kPa). He completed a 12-month program of caloric restriction and resistance training. Serum proteomic analysis compared samples from before and after the intervention.
He lost 33.8% of his body weight while preserving skeletal muscle. His liver enzymes normalized and liver stiffness fell 80.6%. Proteomics showed the NET formation pathway as the most significantly upregulated, in contrast to downregulated metabolic pathways. Mapping confirmed higher levels of NETosis-essential proteins, including PAD4, neutrophil elastase, myeloperoxidase and citrullinated histone H3. Upstream signals such as ROS, Akt/mTOR and NADPH oxidase components were also increased.
The case suggests that intensive lifestyle intervention can produce rapid and substantial fibrosis improvement in MASLD, and that a shift from metabolic stress to neutrophil-driven immune activity may accompany tissue remodeling. NETs have been linked to both injury and resolution in different settings, so this finding raises questions rather than settling them.
Caveats are significant. This is a single patient with no control, and fibrosis was assessed by elastography rather than biopsy, so the stiffness drop may partly reflect reduced inflammation and steatosis rather than true collagen regression. Serum proteomics may not reflect liver-specific events, and a causal role for NETosis is unproven. The degree of weight loss is also unusually large and may not be achievable or safe for most patients.
Key Findings
- A 12-month caloric restriction and resistance training program produced 33.8% weight loss with skeletal muscle preserved.
- Liver stiffness fell 80.6% from 18 kPa, and liver enzymes normalized.
- Serum proteomics ranked neutrophil extracellular trap formation as the most upregulated pathway after the intervention.
- PAD4, neutrophil elastase, myeloperoxidase and citrullinated histone H3 were all increased, alongside ROS and Akt/mTOR signaling.
- Metabolic pathways were downregulated while NETosis rose, suggesting a shift from metabolic stress to immune-mediated remodeling.
Methodology
Single-patient case report of a man in his 30s with MASLD, severe obesity and advanced fibrosis who completed a 12-month diet and resistance training program. Liver stiffness and enzymes were tracked, and comparative serum proteomic analysis with pathway mapping was done before and after the intervention.
Study Limitations
A single uncontrolled case cannot establish causality or generalizability, and the 33.8% weight loss is exceptional. Fibrosis was judged by liver stiffness, not histology, and serum proteomics may not reflect hepatic processes. Only the abstract was available for this summary, so methodological details are limited.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: